Clinical trial

Micophenolate Mofetil Versus Azathioprine in Myocarditis

NCT05237323

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-10-01

PhasePHASE3

Study timeline

Study start (actual)2020-10-01Date precision: day

Registry last updated2025-07-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lymphocytic Myocarditis (Disorder)unresolved

Heart Failureverified · MONDO: heart failure

Dilated Cardiomyopathyverified · MONDO: dilated cardiomyopathy

Cardiomyopathiesverified · MONDO: cardiomyopathy

Sudden Cardiac Deathverified · MONDO: obsolete sudden cardiac death

Interventions

mycophenolate mofetil 2 g per dayDRUG

azathioprine of 150 [75; 150] mg per dayDRUG

Sponsors & collaborators

I.M. Sechenov First Moscow State Medical Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05237323 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.